Calmare Therapeutics to Present at the 5th Annual SeeThruEquity Microcap Investor Conference
Date: Tuesday, May 31, 2016; Venue: Convene, 730 Third Avenue, New York City
FAIRFIELD, CT / ACCESSWIRE / May 25, 2016 / Calmare Therapeutics Incorporated (CTTC) (CTI), the pain mitigation company, will present at the 5th Annual SeeThruEquity Microcap Investor Conference at Convene on 730 Third Avenue in New York City on May 31, 2016.
"This is a great venue to share the Calmare story," said CTI President & CEO Conrad Mir. "And we are thankful for being given the opportunity to present."
